High Tower Advisors, LLC Danaher Corp Transaction History

High Tower Advisors, LLC

$64.2 Billion
Q2 2024

A detailed history of High Tower Advisors, LLC transactions in Danaher Corp stock. As of the latest transaction made, High Tower Advisors, LLC holds 352,482 shares of DHR stock, worth $86.7 Million. This represents 0.14% of its overall portfolio holdings.

Number of Shares

352,482

Previous 355,817 0.94%

Holding current value

$86.7 Million

Previous $88.9 Million 0.89%

% of portfolio

0.14%

Previous 0.15%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	SELL	$235.51 - $267.98 $785,425 - $893,713	-3,335 Reduced 0.94%	352,482 $88.1 Million
Q1 2024 May 06, 2024	BUY	$224.58 - $256.19 $207,287 - $236,463	923 Added 0.26%	355,817 $88.9 Million
Q4 2023 Feb 12, 2024	BUY	$185.1 - $233.13 $1.5 Million - $1.88 Million	8,080 Added 2.33%	354,894 $82.1 Million
Q3 2023 Nov 08, 2023	BUY	$233.08 - $265.59 $2.41 Million - $2.75 Million	10,351 Added 3.08%	346,814 $86 Million
Q2 2023 Aug 14, 2023	SELL	$224.99 - $256.14 $4.06 Million - $4.62 Million	-18,033 Reduced 5.09%	336,463 $80.8 Million
Q1 2023 May 11, 2023	SELL	$239.75 - $277.0 $826,178 - $954,542	-3,446 Reduced 0.96%	354,496 $89.3 Million
Q4 2022 Feb 08, 2023	BUY	$241.42 - $282.29 $241 - $282	1 Added 0.0%	357,942 $95 Million
Q3 2022 Nov 09, 2022	BUY	$247.06 - $1507.4 $2.34 Million - $14.3 Million	9,488 Added 2.72%	357,941 $92.4 Million
Q2 2022 Aug 10, 2022	SELL	$237.11 - $299.66 $673,866 - $851,633	-2,842 Reduced 0.81%	348,453 $88.4 Million
Q1 2022 May 12, 2022	SELL	$257.27 - $315.76 $3.3 Million - $4.05 Million	-12,812 Reduced 3.52%	351,295 $103 Million
Q4 2021 Feb 10, 2022	BUY	$292.08 - $329.01 $31.2 Million - $35.2 Million	106,950 Added 41.59%	364,107 $120 Million
Q3 2021 Nov 12, 2021	SELL	$272.21 - $332.43 $4.55 Million - $5.56 Million	-16,713 Reduced 6.1%	257,157 $78.2 Million
Q2 2021 Aug 06, 2021	BUY	$225.08 - $271.69 $2.03 Million - $2.45 Million	9,009 Added 3.4%	273,870 $73.5 Million
Q1 2021 May 10, 2021	BUY	$212.38 - $245.9 $1.95 Million - $2.26 Million	9,189 Added 3.59%	264,861 $59.8 Million
Q4 2020 Feb 10, 2021	BUY	$212.5 - $245.46 $5.48 Million - $6.33 Million	25,804 Added 11.23%	255,672 $56.8 Million
Q3 2020 Nov 13, 2020	BUY	$177.16 - $215.33 $8.29 Million - $10.1 Million	46,801 Added 25.56%	229,868 $49.5 Million
Q2 2020 Aug 10, 2020	BUY	$128.7 - $176.83 $312,097 - $428,812	2,425 Added 1.34%	183,067 $32.4 Million
Q1 2020 May 21, 2020	BUY	$121.39 - $169.05 $208,426 - $290,258	1,717 Added 0.96%	180,642 $25.1 Million
Q4 2019 Feb 14, 2020	SELL	$133.47 - $153.48 $1.11 Million - $1.27 Million	-8,291 Reduced 4.43%	178,925 $27.5 Million
Q3 2019 Nov 12, 2019	BUY	$135.4 - $146.47 $508,156 - $549,701	3,753 Added 2.05%	187,216 $27 Million
Q2 2019 Aug 13, 2019	BUY	$124.88 - $143.73 $7.17 Million - $8.25 Million	57,379 Added 45.51%	183,463 $26.2 Million
Q1 2019 May 15, 2019	BUY	$97.62 - $132.29 $154,044 - $208,753	1,578 Added 1.27%	126,084 $16.7 Million
Q4 2018 Feb 14, 2019	BUY	$94.85 - $109.54 $204,401 - $236,058	2,155 Added 1.76%	124,506 $12.8 Million
Q3 2018 Nov 09, 2018	BUY	$98.13 - $108.9 $35,621 - $39,530	363 Added 0.3%	122,351 $13.3 Million
Q2 2018 Aug 14, 2018	BUY	$96.1 - $103.24 $2.11 Million - $2.27 Million	22,001 Added 22.0%	121,988 $12 Million
Q1 2018 May 15, 2018	BUY	$92.16 - $103.8 $126,351 - $142,309	1,371 Added 1.39%	99,987 $9.78 Million
Q4 2017 Feb 14, 2018	SELL	$85.26 - $94.62 $250,920 - $278,466	-2,943 Reduced 2.9%	98,616 $9.15 Million
Q3 2017 Nov 14, 2017	SELL	$79.29 - $88.45 $2.35 Million - $2.62 Million	-29,673 Reduced 22.61%	101,559 $8.7 Million
Q2 2017 Aug 14, 2017	BUY	N/A	131,232	131,232 $11.1 Million

Others Institutions Holding DHR

# of Institutions

2,443

Shares Held

563M

Call Options Held

3.91M

Put Options Held

4.1M

View Full List

About DANAHER CORP

Ticker DHR
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 727,963,008
Market Cap $179B
Description
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automati...

More about DHR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of High Tower Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on High Tower Advisors, LLC with notifications on news.

Account

High Tower Advisors, LLC Danaher Corp Transaction History